Back to funds

Omega Fund Management, LLC

Updated 6 days ago

Managed by Omega Fund Management, Llc • Latest filing Q3 2026

Portfolio value
$125.2M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$286.5M
Q1 2026$163.1M
Q2 2026$185.7M
Q3 2026$125.2M

Top holdings

10 positions as of Q3 2026

View filing
N

Nuvation Bio Inc.

Value
$40M
Shares
7.15M
% Port
31.99%
B

Bicara Therapeutics Inc.

Value
$32.8M
Shares
1.76M
% Port
26.17%
B

Beta Bionics Inc.

Value
$18.3M
Shares
962.0K
% Port
14.59%
?
4.N/A

BridgeBio Oncology Therapeutics Inc.

Value
$13.5M
Shares
3.29M
% Port
10.78%
?
5.N/A

Kestra Med Technologies Ltd

Value
$10.3M
Shares
362.4K
% Port
8.19%
I

Immunic, Inc.

Value
$4M
Shares
430.2K
% Port
3.20%
S

Sana Biotechnology, Inc.

Value
$2.5M
Shares
843.8K
% Port
1.97%
I

ImageneBio, Inc.

Value
$2.1M
Shares
455.4K
% Port
1.67%
E

enGene Holdings Inc.

Value
$1.8M
Shares
876.4K
% Port
1.40%
O

Odyssey Therapeutics Inc.

Value
$64K
Shares
2.9K
% Port
0.05%

Explore